Latest posts tagged with #MultScler on Bluesky
🎥 Marcello Moccia comments on the association between neurofilament and invisible symptoms of #MultipleSclerosis, including cognitive dysfunction, depression, and fatigue:
👉 buff.ly/eW8A7YG 👈
#MS #MultScler #Neuroscience #Neurology #EAN2025 #MedSky
In an interview from #EAN2025, Celia Oreja-Guevara discusses the importance of early detection of silent progression in patients with #MS.
Click here to watch:
👉 buff.ly/YhEAYwv 👈
#MultScler #MultipleSclerosis #Neurology #MedSky
Watch our interview with Marcello Moccia to hear about a study comparing different age-derived cut-offs for plasma neurofilament light chain in #MultipleSclerosis.
Click here:
👉 buff.ly/yaa0Q9L
#MS #MultScler #Neuroscience #Neurology #EAN2025
What is the impact of the new McDonald diagnostic criteria for #MultipleSclerosis? 🧠
Marcello Moccia discussed this in a recent interview:
🎥 buff.ly/9DcoI2r
#MS #MultScler #Neuroscience #Neurology #EAN2025 #MedSky
Want to hear the details of a study investigating soluble factors that contribute to broad rim lesion formation in #MultipleSclerosis?
Then make sure to check out our interview with Joost Smolders from #EAN2025:
🎥 buff.ly/P7pXCa9
#CTSM #MS #MultScler #Neurology #MedSky
Want to find out about the recent revision of the McDonald criteria for the diagnosis of #MultipleSclerosis?🧠
Click here to watch our insightful interview with Marcello Moccia:
👉 buff.ly/1E9VzZJ
#MS #MultScler #Neuroscience #Neurology #EAN2025 @ean.org #MedSky
The EnvIMS study was a multinational case-control study investigating childhood infections and their impact on #MultipleSclerosis onset in adults.
Caterina Ferri shares the findings in an interview from #EAN2025:
🎥 buff.ly/RRgMxfp
#MS #MultScler #CTSM #Neurology #MedSky
In an interview from #EAN2025, Celia Oreja-Guevara comments on the inclusion of the central vein sign in the McDonald diagnostic criteria for #MultipleSclerosis to allow for its differentiation from similar diseases:
👉 buff.ly/yR8xfQv
#MultScler #Neurology #Neuroscience #MedSky @ean.org
Want to hear as Celia Oreja-Guevara shares her highlights in #MultipleSclerosis from #EAN2025? 🧠
Make sure to check out our interview with her by clicking here:
👉 buff.ly/4YnGgfV 👈
#MS #MultScler #MedSky #Neurology @ean.org
As it's #WorldMSDay, why not listen to our podcast with leading experts who provide insight into the recent revision of the McDonald diagnostic criteria for #MultipleSclerosis?🧠
Check it out here:
🎧 buff.ly/5R4rqcU
#MS #MultScler #Neurology #MSAwareness #MedSky
#AANAM | Enric Monreal discusses the role of biomarkers in transitioning from evidence-based medicine to personalized medicine in #MultipleSclerosis:
🎥 buff.ly/cCDoeEs
#MedSky #MS #MultScler #Neurology #Neuroscience
#MSWeek | Enric Monreal presents findings of a study investigating the predictive value of the combination of CSF and serum biomarkers at disease onset in #MultipleSclerosis. 🧠🩸
Watch here:
🎥 buff.ly/UWJgWR8
#MS #MultScler #Neurology #AANAM
Metabolic and lipid alterations in multiple sclerosis linked to disease severity #MultScler #MassSpec journals.sagepub.com/doi/10.1177/...
At the European CAR T-cell meeting, we spoke with Johanna Richter to hear about the preliminary data from a single-center experience with CD19-directed CAR-T in patients with #MultipleSclerosis.
Watch here:
👉 buff.ly/Xyuvgwu
#MS #MultScler #CART25 #Neurology
There is a need to enhance the use of advanced MRI in MS diagnosis and monitoring.🧠
Hear more about this in our interview with Dr Serena Borrelli:
🎥 https://buff.ly/3CD7dlY
#MS #MultScler #MultipleSclerosis #EAN2024 #Neuroscience
🎥 Dr Serena Borrelli discusses a proposed approach for simplifying the assessment of central vein sign positivity in clinical practice.
Click here to watch:
👉 https://buff.ly/40nXHuQ 👈
#MS #MultScler #MultipleSclerosis #EAN2024 #Neuroscience
#ECTRIMS2024 | Emilio Portaccio outlines the two ways disability accrual occurs in #MultipleSclerosis – relapse-associated worsening (RAW) & progression independent from relapse activity (PIRA).
Click here:
👉 https://buff.ly/4gZeUl3
#MultScler #MS #Neurology #Neuroscience
Have you listened to our newest podcast yet?🤔🎧
Don't miss out on this fantastic episode if you want to gain insight into the latest updates to the McDonald diagnostic criteria for #MultipleSclerosis.🧠
Listen here:
👉 https://buff.ly/41c1qOe 👈
#MS #MultScler
The central vein sign (CVS) is a central linear hypointensity within lesions on T2*-weighted imaging.
Celia Oreja-Guevara discusses its clinical value in the diagnosis of #MultipleSclerosis:
👉 https://buff.ly/4iAq15x 👈
#MS #MultScler #Neuroscience #Neurology
What are the similarities between chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and #MultipleSclerosis?🤔
Watch our interview with Alicja Kalinowska to find out:
👉 https://buff.ly/49HS5jb
#MS #MultScler
Earlier this year, we interviewed Maya Zeineddine to hear about the differences between treatment with natalizumab and anti-CD20 monoclonal antibodies in #MultipleSclerosis.
Watch here:
👉 https://buff.ly/3ZAA42V
#MS #MultScler #ECTRIMS2024 #Neuroscience
#CARTCell therapy has revolutionized the treatment of hematological malignancies and is now being considered as a potential treatment for neurological conditions, including #MultipleSclerosis!
Learn more from Krish Patel here:
👉https://buff.ly/3Z7S7MG
#ECTRIMS2024 #MS #MultScler
It was a pleasure to interview Anneke Van der Walt, who provided insight into evobrutinib and other BTK inhibitors for the treatment of #MultipleSclerosis.
Click here to watch:
👉 https://buff.ly/3Z8JMbw
#ECTRIMS2024 #MultScler #MS #Neuroscience #Neurology
In an interview from #ECTRIMS2024, Helen Tremlett introduces the concept of a prodromal phase in #MultipleSclerosis and comments on how it has been neglected.
Watch it here:
👉 https://buff.ly/3B1PiVt
#MultScler #MS #Neuroscience #Neurology
Our new podcast is live! 🎧
Hear about the latest updates to the McDonald diagnostic criteria for #MultipleSclerosis from leading experts in the field. 🧠
Click here to listen:
👉 https://buff.ly/41c1qOe 👈
#MS #MultScler #Neurology #Neuroscience
🎥 Lilyana Amezcua, MD, FAAN, discusses the Phase IV CHIMES trial, evaluating ocrelizumab’s efficacy in Black/African American and Hispanic/Latino individuals with relapsing #MultipleSclerosis:
👉 https://buff.ly/4fAeFMS 👈
#MS #MultScler #AANAM #CTSM #TrialUpdate #Neuroscience #Neurology
Want to hear about the current state of clinical evidence regarding the use of stem cell therapies in patients with #MultipleSclerosis?
Watch our interview with Andrew Wolf, MD:
👉 https://buff.ly/48ZC7R9 👈
#MS #MultScler #AANAM #Neurology #Neuroscience
